Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 938 (116th)

BLOCKING Act of 2019

openUnited States· United States Congress· EN

Introduced

31 January 2019

Last action

2 May 2019 · Reported

Status

Placed on the Union Calendar, Calendar No. 24.

Sponsors

Rep. Schrader, Kurt [D-OR-5], Rep. Carter, Earl L. "Buddy" [R-GA-1], Rep. Craig, Angie [D-MN-2], Rep. Dingell, Debbie [D-MI-6], Rep. Ruiz, Raul [D-CA-25], Rep. Pallone, Frank [D-NJ-6], Rep. Eshoo, Anna G. [D-CA-18], Rep. Kennedy, Joseph P., III [D-MA-4], Rep. Matsui, Doris O. [D-CA-7], Rep. Rush, Bobby L. [D-IL-1], Rep. Van Drew, Jefferson [R-NJ-2], Rep. Clarke, Yvette D. [D-NY-9], Rep. Walden, Greg [R-OR-2], Rep. Schakowsky, Janice D. [D-IL-9], Rep. McAdams, Ben [D-UT-4], Rep. Mucarsel-Powell, Debbie [D-FL-26], Rep. Meadows, Mark [R-NC-11]

Subjects

Healthcare

Source updated

7 April 2025

Healthcare

Summary

Bringing Low-cost Options and Competition while Keeping Incentives for New Generics Act of 2019 or the BLOCKING Act of 2019 This bill modifies provisions related to market exclusivity for a generic drug. Currently, the Food and Drug Administration (FDA) awards 180 days of exclusivity on the market to a first applicant to file a qualifying application for market approval of a generic drug. Generally, this exclusivity period begins upon a first applicant's commercial marketing of the drug. The bill authorizes the FDA to approve a subsequent generic drug application prior to a first applicant's first date of commercial marketing if (1) the subsequent application is ready for full approval, (2) a first applicant's application has been pending for at least 30 months, and (3) the approval of a first applicant's application is not precluded by patent infringement claims asserted against that first applicant.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 31 January 2019

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  2. 31 January 2019

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 31 January 2019

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 2 February 2019

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

  5. 27 March 2019

    Committee

    Forwarded by Subcommittee to Full Committee by Voice Vote .

    Source: Committee

  6. 27 March 2019

    Committee

    Subcommittee Consideration and Mark-up Session Held.

    Source: Committee

  7. 3 April 2019

    Reported

    Ordered to be Reported by Voice Vote.

    Source: Committee

  8. 3 April 2019

    Committee

    Committee Consideration and Mark-up Session Held.

    Source: Committee

  9. 2 May 2019

    Calendars

    Placed on the Union Calendar, Calendar No. 24.

    Source: Calendars

  10. 2 May 2019

    Reported

    Reported by the Committee on Energy and Commerce. H. Rept. 116-46.

    Source: Committee

  11. 2 May 2019

    Reported

    Reported by the Committee on Energy and Commerce. H. Rept. 116-46.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

6 official files

Reported in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Reported in House (text)

    Reported in House · EN · 2 May 2019

    ViewDownloadOpen at official source

  • Reported in House (PDF)

    Reported in House · EN · 2 May 2019

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Reported to House

    summary · EN · 2 May 2019

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 31 January 2019

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (PDF)

    Introduced in House · EN · 31 January 2019

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 31 January 2019

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.